PRESCRIPTION MONITORING PROGRAM USING THE CONNECTICUT PRESCRIPTION MONITORING AND REPORTING SYSTEM (CPMRS)
|
|
- Posy Taylor
- 5 years ago
- Views:
Transcription
1 PRESCRIPTION MONITORING PROGRAM USING THE CONNECTICUT PRESCRIPTION MONITORING AND REPORTING SYSTEM (CPMRS)
2 Presenters Connecticut Department of Consumer Protection, Prescription Monitoring Program Nana Kittiphane, HPA I & Xaviel Soto, Program Manager
3 Objectives Program Overview o Background o CPMRS Data o Connecticut Legislation Patient Queries - CPMRS (PMP AWARxE) o
4 Background In 2006, legislators enacted CGS: Section 21a-254 providing for a PMP. The PMP became fully operational in February July 1, 2008, the CPMRS went live. Funding through the U.S. Department of Justice (DOJ) and the U.S. Department of Health & Human Services (HHS)
5 CPMRS Data # of Controlled Substance Prescriptions/Year 6,300,000 6,200,000 6,100,000 6,000,000 5,900,000 6,064,563 6,249, ,800,000 5,700,000 5,829,240 5,990,233 5,600,000 # of Prescriptions/Year
6 # of Controlled Substance Prescriptions/County 2015
7 CPMRS Data Most Prescribed Controlled Substances Alprazolam Oxycodone & Acetaminophen Zolpidem Tartrate Clonazepam Lorazepam
8 What is the CPMRS? CT Prescription Monitoring and Reporting System Collection of prescription data for Schedule II-V drugs Data stored in centralized, relational database Data collection began in July 2008 Data submission o Over 600 in-state pharmacies o 400 out-of-state mail order and Internet pharmacies 3 years of accessible data
9 What Kind of Drugs Are Reported? SCHEDULE II Oxycontin, marijuana, methadone, morphine, Ritalin SCHEDULE III Lortab, Vicodin, testosterone, Tylenol with Codeine SCHEDULE IV Valium, Xanax, Darvocet-N100, Ambien SCHEDULE V Lomotil, Robitussin AC *Complete list of scheduled drugs is available at the U.S. Food and Drug Administration s (FDA) website.
10 Who Can Access Information? Prescribers for their patients only Delegates (licensed and unlicensed) Pharmacists for their patients only Authorized Law Enforcement/Regulatory Personnel may obtain information from the system only when there is an active investigation.
11 Mandatory Registration Public Act (Effective 6/21/2013) Signed into law on June 21, Mandatory Reporting by prescribers dispensing controlled substances from their practice or facility All prescribers in possession of a Controlled Substance Practitioner (CSP) registration, will be required to register as a user with the Connecticut Prescription Monitoring and Reporting System (CPMRS) at
12 Continue Public Act (Effective 6/21/2013) Any prescribers who dispense controlled substances from their practice, or facility, etc., will be required to upload dispensing information into the CPMRS Data Collection website at No person or employer shall prohibit, discourage or impede a prescribing practitioner or pharmacist from requesting controlled substance prescription information. Identify other products or substances to be included in the electronic prescription drug monitoring program. Requires pharmacies to report weekly instead of twice a month.
13 Mandatory Usage Public Act (Effective 10/01/2015) Prior to prescribing greater than a 72-hour supply of any controlled substance (Schedule II - V) to any patient, the prescribing practitioner or such practitioner's authorized agent who is also a licensed health care professional shall review the patient's records in the CPMRS at Whenever a prescribing practitioner prescribes controlled substances for the continuous or prolonged treatment of any patient, such prescriber, or such prescriber's authorized agent who is also a licensed health care professional, shall review, not less than once every 90 days, the patient's records in the CPMRS.
14 June Special Session Public Act 15-5, Sec. 354 (Effective 10/01/2015) On and after July 1, 2016, each pharmacy, nonresident pharmacy, outpatient pharmacy in a hospital or institution, and dispenser shall report all controlled substance prescriptions dispensed immediately upon, but in no event later than the next business day after, dispensing such prescriptions. Collection website at
15 Public Act (Effective 07/01/2016) Daily reporting will not apply to veterinary dispensaries. For veterinary dispensaries, dispensation reports are still due weekly. User roles in the CPMRS has been expanded to include both licensed and unlicensed delegates. Patient query must be conducted at least once a year for prescription of Schedule V nonnarcotic controlled substance, for the continuous or prolonged treatment of any patient, such prescribing practitioner, or such prescribing practitioner's authorized agent, shall review, not less than annually, the patient's records in such prescription drug monitoring program.
16 Connecticut Prescription Monitoring & Reporting System (CPMRS) Register to become a user. Log-in Page visit If first time user, click on Create an Account.
17 CPMRS Registration Page Registration Tutorial Required Fields
18 CPMRS Registration Page Not Complete Form Upload Required Documents
19 Include a government issued I.D. Card CPMRS Registration Page PMP Fax Number Have form notarized by a license notary Auto-Registration is now available in the CPMRS Sign and upload or fax the notarized form to DCP at (860)
20 CPMRS Login Page Login
21 CPMRS Home Page Prescriber /Pharmacist Dashboard Delegate Dashboard CPMRS Home Page
22 CPMRS Patient Request Tutorial Include First Name & Last Name. Check Partial Search You may change the time frame here Prescribers attest the information is for a patient they are providing treatment.
23 CPMRS Patient Report Patient s Name Summary PDF & Excel Prescriber Name & Address Pharmacy Name & Address
24 USE OF THE REPORT: Things You May Do The practitioner may: o Discuss the findings of the report, not the contents of the report, with; The patient, Another health care provider treating the patient A dispenser who has dispensed or will dispense medications to the patient
25 USE OF THE REPORT: Thing(s) You Can t Do You may NOT share the actual report with anyone not involved in the treatment of the patient.
26 Continue CPMRS Data The data is not perfect. The report is based on search criteria entered and data entered by the dispensing pharmacy. For more information on a prescription, contact the dispensing pharmacy or the prescriber.
27 CPMRS Request History Select Name Refresh & View Click to see results
28 CPMRS MyRx User DEA # Include Date Range
29 CPMRS MyRx PDF & Excel DEA # Patient Info
30 CPMRS - Features Existing Clinical Alerts (Threshold, MME/d, Opiod/Benzodiapine) Upcoming Prescriber Reports Mobile Application Patient Alerts
31 QUESTIONS?
32 Program Contact Information Presented By: Nana Kittiphane, HPA I Xaviel Soto, Program Manager Program Phone #: (860) Fax #: (860) dcp.pmp@ct.gov DCP PMP Website: CPMRS Website: PMP Clearinghouse:
Delegator Dashboard User Guide
Delegator Dashboard User Guide ULP Delegator Dashboard Technical Guide This guide is intended for a Prescriber or Pharmacist who is utilizing Delegates to facilitate PDMP data access. A separate guide
More informationNew Mexico. Contact Information. State Registrant Totals and Population. PDMP name: NM PMP
Statistics website: Ryba, Peter, PharmD - PMP Director 5500 San Antonio Drive NE, Suite C Albuquerque NM 87109 Office: (505) 222-9818 Fax: (505) 222-9845 Email: peter.ryba@state.nm.us New Mexico PDMP name:
More informationFrequently Asked Questions
1. What is dispensing? Frequently Asked Questions DO I NEED A PERMIT? Dispensing means the procedure which results in the receipt of a prescription drug by a patient. Dispensing includes: a. Interpretation
More informationNevada. Contact Information. State Registrant Totals and Population
Statistics website: Long, Yenh - Program Administrator 431 W Plumb Ln Reno NV 89509 Office: (775) 687-5694 Fax: (775) 687-5161 Email: ylong@pharmacy.nv.gov Nevada PDMP name: Prescription Controlled Substance
More informationGeorgia DPH. Prescription Title Drug Heading Monitoring Program Program. Sheila Pierce April 2018
Georgia DPH Prescription Title Drug Heading Monitoring Program Program Sheila Pierce April 2018 What is the PDMP? Legislative Mandates Registration Requirements How to use the PDMP Next Steps for Prescribers
More informationIN THE UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF FLORIDA PANAMA CITY DIVISION COUNTS ONE THROUGH ONE HUNDRED. A.
IN THE UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF FLORIDA PANAMA CITY DIVISION UNITED STATES OF AMERICA SEALED v. INDICTMENT THOMAS G. MERRILL / THE GRAND JURY CHARGES: COUNTS ONE THROUGH
More informationPrescription Monitoring Programs - Legislative Trends and Model Law Revision
Prescription Drug Monitoring Programs Training and Technical Assistance Center Webinar Series National Alliance for Model State Drug Laws: Legislative Round-Up July 22, 2015 Prescription Monitoring Programs
More informationOhio. Contact Information. State Registrant Totals and Population
PDMP name: OARRS Agency responsible: State of Ohio Board of Pharmacy Agency type: Pharmacy Board PDMP email: info@pharmacy.ohio.gov PDMP website: www.ohiopmp.gov Enrollment website: https://ohio.pmpaware.net
More informationPrescription Monitoring Program:
Massachusetts Department of Public Health Prescription Monitoring Program: The Massachusetts Prescription Monitoring Tool (MassPAT) November 1, 2016 Goals of the Session Understand the mission and responsibilities
More informationMississippi. Contact Information. State Registrant Totals and Population
Statistics website: Mueller, Stephanie - PMP Director 6360 I-55 North, Suite 400 Jackson, MS 39211 Office: (601) 899-0138 Fax: (601) 899-8904 Email: smueller@mbp.ms.gov Mississippi PDMP name: MS PMP Agency
More informationAlaska. Contact Information. State Registrant Totals and Population. PDMP name: AKPDMP
Statistics website: Carrillo, Laura - PDMP Manager 550 W. 7th Ave, Ste 1500 Anchorage AK 99501 Office: (907) 269-8404 Fax: (907) 465-2974 Email: laura.carrillo@alaska.gov Alaska PDMP name: AKPDMP PDMP
More informationOffice of Inspector General
Office of Inspector General Mary Reinle Begley Inspector General Division of Health Care Division of Regulated Child Care Division of Audits & Investigations Division of Health Care Health Care facility
More informationPrescription Drug Monitoring Program (PDMP)
Prescription Drug Monitoring Program (PDMP) New York State Information contained in this presentation is accurate as of September 2017 Meet the Speaker Anita Murray, R.Ph., Deputy Director Bureau of Narcotic
More informationPuerto Rico. Contact Information. State Registrant Totals and Population. PDMP name: PR PDMP
Statistics website: Rodriguez, Cieni - Program Manager Carr. No. 2 Km 8.2, Bo. Juan Sanchez Bayamon, PR 00960 Office: (787) 763-7575 Fax: (787) 763-3152 Email: cieni.rodriguez@assmca.pr.gov Puerto Rico
More informationDistrict of Columbia Prescription Drug Monitoring Program
District of Columbia Prescription Drug Monitoring Program What Our Users Need to Know Health Regulation and Licensing Administration Pharmaceutical Control Division February 28, 2017 1 Mission Statement
More informationMassachusetts. Contact Information. State Registrant Totals and Population. PDMP name: MA Prescription Monitoring Program
Massachusetts PDMP name: MA Prescription Monitoring Program PDMP region: Agency responsible: Department of Public Health Agency type: Department of Health PDMP email: mapmp.dph@massmail.state.ma.us PDMP
More informationTennessee. Contact Information. State Registrant Totals and Population. PDMP name: CSMD
Statistics website: Bess, D. Todd - Director, CSMD Program 665 Mainstream Drive Nashville TN 37243 Office: (615) 253-1305 Fax: Email: david.bess@tn.gov Tennessee PDMP name: CSMD PDMP region: South Agency
More informationStates that Allow Prescribers and/or Dispensers to Appoint a Delegate to Access the PMP
States that Allow Prescribers and/or Dispensers to Appoint a Delegate to Access the PMP Research current through May 2016. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of
More informationSTATE OF TEXAS TEXAS STATE BOARD OF PHARMACY
STATE OF TEXAS TEXAS STATE BOARD OF PHARMACY REQUEST FOR INFORMATION NO. 515-15-0002 PRESCRIPTION DRUG MONITORING PROGRAM Reference: CLASS: 920 ITEM: 05 Posting Date: 12/08/2014 RESPONSE DEADLINE: 01/05/2015
More informationPrescription Drug Monitoring Program (PDMP)
Prescription Drug Monitoring Program (PDMP) New Jersey Information contained in this presentation is accurate as of September 2017 Meet the Speaker Sindy Paul, MD, MPH, FACPM Medical Director - NJ Board
More informationColorado. Contact Information
Colorado PDMP name: Prescription Drug Monitoring Program PDMP region: Agency responsible: Colorado State Board of Pharmacy Agency type: Pharmacy Board PDMP email: pdmpinqr@state.co.us PDMP website: https://www.colorado.gov/pacific/dora/pdmp
More informationConnecticut Department of Consumer Protection, Medical Marijuana Program
Connecticut Department of Consumer Protection, Medical Marijuana Program NASCIO 2014 Recognition Awards Category: Digital Government: Government to Business Contact: John Gadea, Jr, Rph., Director Xaviel
More informationMedication Diversion and Prescription Drug Abuse in the Long Term Care Setting. Objectives
Medication Diversion and Prescription Drug Abuse in the Long Term Care Setting Objectives Discuss: Learn about signs of potential diversion and recognize an impaired healthcare provider. Help to identify
More informationMichigan. Contact Information. State Registrant Totals and Population. PDMP name: MAPS
Michigan PDMP name: MAPS PDMP region: Agency responsible: Bureau of Professional Licensing, Drug Monitoring Section Agency type: Professional Licensing Agency PDMP email: BPL-MAPS@michigan.gov PDMP website:
More informationMassachusetts Prescription Monitoring Program
Massachusetts Prescription Monitoring Program PDMP Training and Technical Assistance Center at Brandeis University in partnership with the Bureau of Justice Assistance August 8, 2012 Massachusetts Department
More informationNorth Carolina. Contact Information. State Registrant Totals and Population. PDMP region: PDMP name: Agency responsible:
PDMP name: Agency responsible: Agency type: PDMP email: PDMP website: Enrollment website: Query website: Data upload website: Statistics website: North Carolina PDMP region: South North Carolina Department
More informationKentucky. Kentucky Cabinet for Health and Family Services Office of Inspector General
PDMP name: Agency responsible: Agency type: PDMP email: PDMP website: Enrollment website: Query website: Data upload website: Statistics website: Kentucky Kentucky Cabinet for Health and Family Services
More informationHydrocodone Prescribing and the New Texas PMP
Hydrocodone Prescribing and the New Texas PMP MARC L. FLEMING, PHD, MPH, RPH ASSISTANT PROFESSOR, DEPARTMENT OF PHARMACEUTICAL HEALTH OUTCOMES & POLICY UNIVERSITY OF HOUSTON, COLLEGE OF PHARMACY Hydrocodone
More informationDrug Diversion: Enforcement Trends, Investigation, & Prevention
Drug Diversion: Enforcement Trends, Investigation, & Prevention REGINA F. GURVICH, MBA, CHC, CHPC Agenda Definitions, causes, and sources Regulations and enforcement trends Role of the Compliance Officer
More informationPrescription Drug Monitoring Program (PDMP)
Prescription Drug Monitoring Program (PDMP) West Virginia Information contained in this presentation is accurate as of October 2017 What is a Prescription Drug Monitoring Program? A PDMP/PMP is a statewide
More informationBuilding a Common REMS Platform: Use Case Guide for Prescriber Certification
Building a Common REMS Platform: Use Case Guide for Prescriber Certification Thank you for participating in our first Common REMS Platform Workshop! During this workshop, FDA will be presenting its proposed
More informationPrescription Monitoring Program State Profiles - California
Prescription Monitoring Program State Profiles - California Research current through December 2014. This project was supported by Grant No. G1399ONDCP03A, awarded by the Office of National Drug Control
More informationPrescription Drug Monitoring Program (PDMP) LOUISIANA. Information contained in this presentation is accurate as of September 2017
Prescription Drug Monitoring Program (PDMP) LOUISIANA Information contained in this presentation is accurate as of September 2017 Meet the Speaker Julie W. Breithaupt PharmD, MBA President Louisiana Pharmacists
More informationEPCS FREQUENTLY ASKED QUESTIONS FOR ELECTRONIC PRESCRIBING OF CONTROLLED SUBSTANCES. Revised: March 2016
FREQUENTLY ASKED QUESTIONS FOR ELECTRONIC PRESCRIBING OF CONTROLLED SUBSTANCES EPCS Revised: March 2016 NEW YORK STATE DEPARTMENT OF HEALTH Bureau of Narcotic Enforcement 1-866-811-7957 www.health.ny.gov/professionals/narcotic
More informationPrescription Monitoring Program State Profiles - Illinois
Prescription Monitoring Program State Profiles - Illinois Research current through December 2014. This project was supported by Grant No. G1399ONDCP03A, awarded by the Office of National Drug Control Policy.
More informationImplementing Systems for Detection and Prevention of Drug Diversion
Implementing Systems for Detection and Prevention of Drug Diversion Mitch Sobel, RPh, Assistant Director of Pharmacy Services Saint Barnabas Medical Center, Livingston, New Jersey Aline Greene, RN, CEN,
More informationFrequently Asked Questions MN Prescription Monitoring Program (PMP)
Frequently Asked Questions MN Prescription Monitoring Program (PMP) Topics: 1. Purpose of the PMP 2. Reporting/Frequency of Reporting 3. Dispensing for Animals 4. Inappropriate Prescribing 5. Accessing
More informationPATIENT NOTICE. If you are already taking any of the above medications, your provider may want to talk to you about alternative treatments.
PATIENT NOTICE Our goal at is to provide quality medical care. Because of our concern for your health and well-being, there are certain types of medications we may not be able to prescribe to you. Examples
More informationPrescription Monitoring Program State Profiles - Michigan
Prescription Monitoring Program State Profiles - Michigan Research current through December 2014. This project was supported by Grant No. G1399ONDCP03A, awarded by the Office of National Drug Control Policy.
More informationNational Association of Boards of Pharmacy PMP Interconnect NABP
National Association of Boards of Pharmacy PMP Interconnect NABP Problems with PMPs: Persons engaging in doctor shopping don t stay in one state, particularly areas that border other states Querying the
More informationPrescriptive Authority in Oregon
Oregon State Board of Nursing Prescriptive Authority in Oregon For Nurse Practitioners and Clinical Nurse Specialists 5/2008/1,000 Welcome to the State of Oregon! This booklet reviews laws and regulations
More informationSouth Carolina Reporting & Identification Prescription Tracking System (SCRIPTS)
South Carolina Reporting & Identification Prescription Tracking System (SCRIPTS) Note! Contents are subject to change and are not a guarantee of payment. Webinar Reminders Webinar Reminders Agenda Welcome
More informationPhysicians receive incentives for eprescribing for Medicare patients; penalties are imposed for noncompliance.
At no cost! Physicians receive incentives for eprescribing for Medicare patients; penalties are imposed for noncompliance. 2012 1 % incentive, 1 % penalty 2013 0.5 % incentive, 1.5 % penalty Beyond no
More informationLegal Issues in Managing Opioid Abuse. Gwen Dayton, JD
Legal Issues in Managing Opioid Abuse Gwen Dayton, JD Faculty Disclosure It is the policy of the Oregon Hospice Association to insure balance, independence, objectivity, and scientific rigor in all its
More informationInterim Commissioner Lauren A. Smith and Members of the Public Health Council
DEVAL L. PATRICK GOVERNOR TIMOTHY P. MURRAY LIEUTENANT GOVERNOR JOHN W. POLANOWICZ SECRETARY LAUREN A. SMITH, MD, MPH INTERIM COMMISSIONER The Commonwealth of Massachusetts Executive Office of Health and
More informationRun Management Reports Tutorial
Run Management Reports Tutorial July 2014 Login to InstyMeds Go to the InstyMeds Web site at: http://webinstymeds.com Enter Username Enter Password Click Login button Click on Reports 2 Select the desired
More informationTechnical Assistance Guide. Enhancing PDMPs: A Comparison of Changes 2010 to 2016
Technical Assistance Guide Enhancing PDMPs: A Comparison of Changes 2010 to 2016 December 2016 This project was supported by Grant No. 2014-PM-BX-K001 awarded by the Bureau of Justice Assistance. The Bureau
More informationEvidence-Based Practices to Optimize Prescriber Use of PDMPs
Evidence-Based Practices to Optimize Prescriber Use of PDMPs Sheri Lawal, MPH, CHES Senior Associate, Substance Use Prevention and Treatment Initiative, The Pew Charitable Trusts Thomas Clark Research
More informationStates that Allow Prescribers and/or Dispensers to Appoint a Delegate to Access the PMP
States that Allow Prescribers and/or Dispensers to Appoint a Delegate to Access the PMP Research current through December 2014. This project was supported by Grant No. G1399ONDCP03A, awarded by the Office
More informationPrescription Monitoring Program State Profiles - Texas
Prescription Monitoring Program State Profiles - Texas Research current through December 2014. This project was supported by Grant No. G1399ONDCP03A, awarded by the Office of National Drug Control Policy.
More informationMcConnell AFB Pharmacy Frequently Asked Questions
McConnell AFB Pharmacy Frequently Asked Questions (click the link in blue to be directed to the answer) 1. What are the pharmacy hours? 2. What are your busiest hours in the pharmacy? 3. When can I process
More informationEMIRATES FOUNDATION USER MANUAL. Interns Manual
EMIRATES FOUNDATION USER MANUAL Interns Manual Table of Contents 1. Registration.2 2. Create Your CV 4 3. Dashboard.9 4. Search Internships.11 5. Email Alerts 14 Interns Manual 1. Registration In order
More informationMaryland. Prescribing and Dispensing Profile. Research current through November 2015.
Prescribing and Dispensing Profile Maryland Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points
More informationTennessee. Tennessee Department of Health, Tennessee Board of Pharmacy Pharmacy Board
PDMP name: Agency Responsible: Agency Type: PDMP Website: PDMP Email: Tennessee Tennessee Department of Health, Tennessee Board of Pharmacy Pharmacy Board http://tn.gov/health/topic/csmd-board csmd.admin@tn.gov
More informationInstyMeds Prescription Writer Tutorial
InstyMeds Prescription Writer Tutorial July 2014 Log in to the InstyMeds Prescription Writer tool Important messages announcing the latest enhancements and notifications are located here. 1. Type in Username
More informationOklahoma. Contact Information. Office: Fax: Statistics
PDMP name: Agency Responsible: Agency Type: PDMP Website: PDMP Email: Vogt, Don - PMP Program Manager 419 NE 38th Terrace Oklahoma City OK 73105 Office: (405) 530-3140 Fax: (405) 524-7619 Email: dvogt@obn.state.ok.us
More informationAn Overview for Inpatient Pharmacies (e.g., hospitals, in-hospital hospices, and long-term care facilities that dispense for inpatient use)
The Transmucosal Immediate Release Fentanyl (TIRF) REMS Access Program An Overview for Inpatient Pharmacies (e.g., hospitals, in-hospital hospices, and long-term care facilities that dispense for inpatient
More informationPMIX ADVANCING PMP DATA SHARING THROUGH STANDARDIZATION AND INNOVATION CARL FLANSBAUM, DIRECTOR, NEW MEXICO PMP CO-CHAIR PMIX WORKING GROUP
PMIX ADVANCING PMP DATA SHARING THROUGH STANDARDIZATION AND INNOVATION CARL FLANSBAUM, DIRECTOR, NEW MEXICO PMP CO-CHAIR PMIX WORKING GROUP PMIX: Past, Current and Future A PMIX Primer What is PMIX? Original
More informationRULES FOR STUDENT POSSESSION AND ADMINISTRATION OF ASTHMA, ALLERGY AND ANAPHYLAXIS MANAGEMENT MEDICATIONS OR OTHER PRESCRIPTION MEDICATIONS
DEPARTMENT OF EDUCATION Colorado State Board of Education RULES FOR STUDENT POSSESSION AND ADMINISTRATION OF ASTHMA, ALLERGY AND ANAPHYLAXIS MANAGEMENT MEDICATIONS OR OTHER PRESCRIPTION MEDICATIONS 1 CCR
More informationAMENDMENT TO SENATE BILL 772. AMENDMENT NO.. Amend Senate Bill 772, AS AMENDED, by. replacing everything after the enacting clause with the following:
*LRB00RLC00a* Rep. Cynthia Soto Filed: //0 000SB0ham00 LRB0 0 RLC 00 a AMENDMENT TO SENATE BILL AMENDMENT NO.. Amend Senate Bill, AS AMENDED, by replacing everything after the enacting clause with the
More informationa remote pharmacy is not necessarily intended to provide permanent??? how do we make it so that it may be only for limited duration.
Board of Pharmacy Administrative Rules Version 12 January 18, 2013 Part 19 Remote Pharmacies 19.1 General Purpose: (a) This Part is enacted pursuant to 26 V.S.A. 2032 which initially authorized the Board
More informationPrescription Monitoring Program State Profiles - Pennsylvania
Prescription Monitoring Program State Profiles - Pennsylvania Research current through December 2014. This project was supported by Grant No. G1399ONDCP03A, awarded by the Office of National Drug Control
More informationA complete step by step guide on how to achieve Meaningful Use Core Set Measures in Medgen EHR.
Medgen EHR A complete step by step guide on how to achieve Meaningful Use Core Set Measures in Medgen EHR. Contents Important information regarding Meaningful Use... 2 How to generate your measure report
More informationSENATE, No STATE OF NEW JERSEY. 216th LEGISLATURE INTRODUCED APRIL 28, 2014
SENATE, No. STATE OF NEW JERSEY th LEGISLATURE INTRODUCED APRIL, 0 Sponsored by: Senator LORETTA WEINBERG District (Bergen) Senator JOSEPH F. VITALE District (Middlesex) Senator JAMES W. HOLZAPFEL District
More informationA Handbook to Help You Understand and Succeed in the Washington Health Professional Services (WHPS) Program
A Handbook to Help You Understand and Succeed in the Washington Health Professional Services (WHPS) Program Washington Health Professional Services P.O. Box 47864 Olympia, WA 98504-7864 360-236-2880 DOH
More information4.35 STUDENT MEDICATIONS
4.35 STUDENT MEDICATIONS General Authority of School Nurses Regarding Student Medications School nurses are not permitted to diagnose medical conditions or prescribe medications, including over-thecounter
More informationEligible Professional Core Measure Frequently Asked Questions
Eligible Professional Core Measure Frequently Asked Questions CPOE for Medication Orders 1. How should an EP who orders medications infrequently calculate the measure for the CPOE objective if the EP sees
More informationMyRx: Final Report PREAMBLE Abstract 1.2 Previous Work Keywords INTRODUCTION 1.1 Overview
MyRx: Final Report By: Heather Klinar (hrk13@terpmail.umd.edu) Adam Anderson (adamwalteranderson@gmail.com) Bingchen Hu (bingchenhu@yahoo.com) Chris Muller (chris.muller@gmail.com) Stephen Gardner (augdog911@gmail.com)
More informationDC Board of Pharmacy and Pharmaceutical Control Update
DC Board of Pharmacy and Pharmaceutical Control Update Shauna K. White, Pharm.D, MS Executive Director Board of Pharmacy Program Manager - Pharmaceutical Control Division September 17, 2016 Objectives
More informationThe Wisconsin epdmp:
The Wisconsin epdmp: Frequently Asked Questions Pursuant to 2015 Wisconsin Act 266, effective April 1, 2017, Wisconsin-licensed physicians and other prescribers must review a patient s records from Wisconsin
More informationNATIONAL ASSOCIATION FOR STATE CONTROLLED SUBSTANCES AUTHORITIES (NASCSA) MODEL PRESCRIPTION MONITORING PROGRAM (PMP) ACT (2016) COMMENT
1 NATIONAL ASSOCIATION FOR STATE CONTROLLED SUBSTANCES AUTHORITIES (NASCSA) MODEL PRESCRIPTION MONITORING PROGRAM (PMP) ACT (2016) SECTION 1. SHORT TITLE. This Act shall be known and may be cited as the
More informationEffective Date: 11/09 Policy Chronicle:
Title: Investigational Drug Service Functions Policy Type: Clinical Operations Replaces (supersedes): Title: N/A Policy Chronicle: Date Original Version of Policy was Effective: 09/06 Reviewer Signature:
More informationWIMCR and CCS FAQ Categories
WIMCR and CCS FAQ Categories WIMCR and CCS General Information and Resources... 1 WIMCR and CCS County Agency Overview... 1 WIMCR Direct Service Checklist... 2 WIMCR and CCS Direct Service and Support...
More informationCONSULTANT PHARMACIST INSPECTION LAW REVIEW
CONSULTANT PHARMACIST LAW REVIEW Florida Consultant Pharmacist s are required in: a. Class I Institutional Pharmacies b. Class II Institutional Pharmacies c. Modified Class II Institutional Pharm. d. Assisted
More informationOn September 4, 2012, the evening shift supervisor called the
Case-in-Point Investigating and Making a Case for Drug Diversion Donna H. Mooney, MBA, RN One of the biggest challenges facing boards of nursing (BONs) is ensuring that a fair disciplinary process occurs
More informationNEW MEXICO PRACTITIONER S MANUAL
NEW MEXICO PRACTITIONER S MANUAL An Informational Outline From the New Mexico Board of Pharmacy 5200 Oakland NE Suite A Albuquerque, New Mexico 87113 505-222-9830 800-565-9102 E-Mail: Debra.wilhite@state.nm.us
More informationSummer Webinar Series. The Prescription Drug Monitoring Program (PDMP) Mandate and Where you Fit In June 21, 2018
1 Summer Webinar Series The Prescription Drug Monitoring Program (PDMP) Mandate and Where you Fit In June 21, 2018 2 Introductions Lindsey Ferris, MPH Program Director, HIE Projects PDMP Subject Matter
More informationSteps Taken to Combat the Opiate Epidemic Through Legal And Technological Channels. Nick Snyder, Esq.
Steps Taken to Combat the Opiate Epidemic Through Legal And Technological Channels Nick Snyder, Esq. How Can We Impact Inappropriate Over-Prescribing of Opioids in Maine? What have other States or Organizations
More informationMEANINGFUL USE TRAINING SCENARIOS GUIDE
MEANINGFUL USE TRAINING SCENARIOS GUIDE A guide to the most common scenarios in becoming a Meaningful User with eclinicalworks Version 9.0. eclinicalworks, Rev D, April 2011. All rights reserved Contents
More informationNot if, but When: Drug Diversion in Hospitals. Christopher Fortier, PharmD, FASHP Chief Pharmacy Officer Massachusetts General Hospital Boston, MA
Not if, but When: Drug Diversion in Hospitals Christopher Fortier, PharmD, FASHP Chief Pharmacy Officer Massachusetts General Hospital Boston, MA Healthcare workers 100,000 annually 1 in 10 Affects people
More informationMedicare Advantage and Part D Compliance Training. 42 CFR Parts and
Medicare Advantage and Part D Compliance Training 42 CFR Parts 422.503 and 423.504 Background > As a Medicare Advantage (MA) and Part D (PDP) Plan Sponsor ( Sponsor ), Blue Cross and Blue Shield Northern
More informationTranscribing Medicines for Adults Policy. Policy Register No:09076 Status: Public. NHSLA Risk Assessment standards
` Transcribing Medicines for Adults Policy Policy Register No:09076 Status: Public Developed in response to: Contributes to CQC Core Standard number: Dept of Health Medicines Regulations, NHSLA Risk Assessment
More informationUnderstanding Diversion in the Pharmacy Kimberly S. New JD BSN RN
Understanding Diversion in the Pharmacy Kimberly S. New JD BSN RN All Rights Reserved Scope of the Problem Diversion can t be prevented entirely Substantial safety, quality, regulatory and legal risk Mitigate
More informationPharmacy Law Home Study for Pharmacists and Pharmacy Technicians Preparing Your Pharmacy for a DEA Inspection
Pharmacy Law Home Study for Pharmacists and Pharmacy Technicians (Knowledge-Based CPE Activity) No sponsorship was received for this law program Program Goal and Objectives The purpose of this home study
More information247 CMR: BOARD OF REGISTRATION IN PHARMACY 247 CMR 21.00: REGISTRATION OF OUTSOURCING FACILITIES. Section
247 CMR 21.00: REGISTRATION OF OUTSOURCING FACILITIES Section 21.01: Purpose 21.02: Outsourcing Facility Registration Requirements 21.03: Provisional Outsourcing Facility Registration Requirements 21.04:
More information10/4/12. Controlled Substances Dispensing Issues and Solutions. Objectives. Financial Disclosure
Controlled Substances Dispensing Issues and Solutions Ronald W. Buzzeo, R.Ph. Chief Compliance Officer November 7, 2012 CE Code: Financial Disclosure I have no actual or potentially relevant financial
More informationPrescriber Use of the PDMP: A Statewide Survey and Multistate Focus Groups
Prescriber Use of the PDMP: A Statewide Survey and Multistate Focus Groups Richard Deyo, MD, MPH Depts. of Family Medicine & Internal Medicine, Oregon Health & Science University Jessica Irvine, MS Acumentra
More informationGENERAL ASSEMBLY OF NORTH CAROLINA SESSION 2017 S 2 SENATE BILL 750* Health Care Committee Substitute Adopted 6/12/18
GENERAL ASSEMBLY OF NORTH CAROLINA SESSION 0 S SENATE BILL 0* Health Care Committee Substitute Adopted /1/ Short Title: Health-Local Confinement/Vet. Controlled Sub. (Public) Sponsors: Referred to: May,
More information-Health Update. Encounter Notification System (ENS) Celebrates Five Years! Welcome
www.crisphealth.org e -Health Update ISSUE 8 Summer 2017 Welcome The e-health Update is a resource that shares current CRISP initiatives as well as pertinent health care related information for our region.
More informationOREGON HEALTH AUTHORITY, DIVISION OF MEDICAL ASSISTANCE PROGRAMS
OREGON HEALTH AUTHORITY, DIVISION OF MEDICAL ASSISTANCE PROGRAMS DIVISION 121 PHARMACEUTICAL SERVICES Non-Medicaid Rules Prescription Drug Monitoring Program 410-121-4000 Purpose The purpose of the Prescription
More informationChapter 1: Overview of Texas Pharmacy Law 1 Contact Hour (Mandatory)
Chapter 1: Overview of Texas Pharmacy Law 1 Contact Hour (Mandatory) By: Katie Blair, PharmD, RPh Author Disclosure: Katie Blair and Elite Professional Education, LLC do not have any actual or potential
More informationMedicare Advantage and Part D Fraud, Waste and Abuse Compliance Training 2015
Medicare Advantage and Part D Fraud, Waste and Abuse Compliance Training 2015 Overview This Medicare Advantage and Part D Fraud, Waste and Abuse Compliance Training for first-tier, downstream and related
More informationMedication Assisted Treatment for Opioid Use Disorders Reporting Requirements
This document is scheduled to be published in the Federal Register on 09/27/2016 and available online at https://federalregister.gov/d/2016-23277, and on FDsys.gov DEPARTMENT OF HEALTH AND HUMAN SERVICES
More informationfor more information visit GradLeaders.com
for CANDIDATES at our Partner Schools how to REGISTER + SEARCH FOR JOBS with your career services portal powered by GradLeaders last updated July 20, 2017 for more information visit how to REGISTER + SEARCH
More informationPHARMACEUTICALS AND MEDICATIONS
DESCHUTES COUNTY ADULT JAIL CD-10-17 L. Shane Nelson, Sheriff Jail Operations Approved by: December 6, 2017 POLICY. PHARMACEUTICALS AND MEDICATIONS It is the policy of Deschutes County Sheriff s Office
More informationPharmaceutical Diversion Prevention, Detection and Incident Response
Pharmaceutical Diversion Prevention, Detection and Incident Response HIPAA Security Officer, Mount Sinai Health System President, Society of Professional Investigators Associate Director of Administration
More informationPrescription Drug Monitoring Programs: Promising Practices to Maximize Their Effectiveness
Prescription Drug Monitoring Programs: Promising Practices to Maximize Their Effectiveness Peter Kreiner, Ph.D. Prescription Monitoring Program Center of Excellence at Brandeis University NGA Meeting September
More informationConnecticut Early Childhood Professional Registry
Connecticut Early Childhood Professional Registry 165 Capitol Avenue, G-35 Hartford, CT 06106 860-713-6983 Margaret.Gustafson@ct.gov TRAINER USE of CT Early Childhood Professional Registry for individuals
More informationAdmission Medication History and Reconciliation Documentation. Froedtert Hospital, Milwaukee WI
Overview of Medication History and Reconciliation Process 2 Overview of Icons Used in the Medication History 2 and Reconciliation Process The Admission Navigator 3 SureScripts Medication Reconciliation
More informationHow to Get the Most Out of Prescription Drug Monitoring Programs
How to Get the Most Out of Prescription Drug Monitoring Programs Target Audience: Pharmacists and Pharmacy Technicians ACPE#: 0202-0000-18-019-L03-P/T Activity Type: Knowledge-based Disclosures I own 40
More information